Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| NEP | P08473 | Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | Charcot-Marie-Tooth diseaseSpinocerebellar ataxiaAsthma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 4 | 0.40 | ||
| NRP1 | O14786 | Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304) | Cancer-related genesCD markersPlasma proteins | 1 | RetinopathySolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 4 | 0.40 | ||
| PAK1 | Q13153 | Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK) | Disease related genesEnzymesHuman disease related genes | EpilepsyIntellectual disability | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 4 | 0.40 | |||
| PHAR1 | Q9C0D0 | Phosphatase and actin regulator 1 | Disease related genesHuman disease related genesPredicted intracellular proteins | Epilepsy | Fusion and delivery mediation | 4 | 0.40 | |||
| PLCB1 | Q9NQ66 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I) (PLC-I) (Phospholipase C-beta-1) (PLC-beta-1) | Disease related genesEnzymesHuman disease related genes | Epilepsy | Fusion and delivery mediationImmune mediationMetabolism mediation | 4 | 0.40 | |||
| RHBT2 | Q9BYZ6 | Rho-related BTB domain-containing protein 2 (Deleted in breast cancer 2 gene protein) (p83) | Disease related genesHuman disease related genesPredicted intracellular proteins | Epilepsy | Fusion and delivery mediationReceptor-signaling mediation | 4 | 0.40 | |||
| SATT | P43007 | Neutral amino acid transporter A (Alanine/serine/cysteine/threonine transporter 1) (ASCT-1) (Solute carrier family 1 member 4) | Disease related genesHuman disease related genesMetabolic proteins | 8 | EpilepsyIntellectual disability | Fusion and delivery mediation | 4 | 0.40 | ||
| SCN4B | Q8IWT1 | Sodium channel regulatory subunit beta-4 | Disease related genesFDA approved drug targetsHuman disease related genes | 1 | Atrial fibrillationLong QT syndrome | Clinical-translation mediationFusion and delivery mediation | 4 | 0.40 | ||
| BANK1 | Q8NDB2 | B-cell scaffold protein with ankyrin repeats | Disease related genesHuman disease related genesPredicted intracellular proteins | Systemic lupus erythematosus | Immune mediationReceptor-signaling mediation | 3 | 0.40 | |||
| MCLN1 | Q9GZU1 | Mucolipin-1 (ML1) (MG-2) (Mucolipidin) (Transient receptor potential channel mucolipin 1) (TRPML1) | Disease related genesHuman disease related genesPotential drug targets | 6 | Corneal dystrophyMucolipidosis | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 3 | 0.40 |